3:04 PM
Aug 14, 2018
 |  BC Extra  |  Company News

Management tracks: Cheng departing Gilead as CMO

Editor's Note: This article was updated on Aug 14, 2018 at 3:50 PM PDT

Gilead Sciences Inc. (NASDAQ:GILD) said CMO Andrew Cheng will leave the company, effective Sept. 7, after five months in the role to pursue another opportunity. Gilead did not say who would replace Cheng, who joined the company in 1999 to lead Gilead’s development-stage programs in HIV/AIDS. He became an EVP in 2015.

Gilead also announced two promotions. Gregg Alton becomes chief patient officer after serving as EVP of corporate and medical affairs. Gilead said that in the newly created role Alton will facilitate access to...

Read the full 405 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >